Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

DNPUF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.42B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.19-11%-0.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$5.42 Billion
Enterprise Value$67.35 Billion
Earnings per Share$270.03
Beta0.45
Outstanding Shares447,504,000

Return

Return on Equity10.76%ROE
Return on Assets5.45%
Return on Invested Capital8.28%

Valuation & Multiples

P/E Ratio19.02P/E Ratio
PEG-24.96PEG
Price to Sales0.01Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue0.14
Enterprise Value to EBIT1.35
Enterprise Value to Net Income1
Total Debt to Enterprise2.07
Debt to Equity0.32Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 30, 2026
EPS
$0.30
Est. $0.18
Revenue
$870.33 M
Est. $849.13 M

Next Earnings Call

Expected Date
January 29, 2027
EPS Estimate
$0.68
Consensus analyst estimate
Revenue Estimate
$1.09 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Sumitomo Pharma Co., Ltd.

3,123 employees
CEO: Toru Kimura

Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across ...